Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities.
about
Rituximab: A Magic Bullet for Pemphigusp38 MAPK Signaling in Pemphigus: Implications for Skin AutoimmunityAn assessment of treatment history and its association with clinical outcomes and relapse in 155 pemphigus patients with response to a single cycle of rituximab.Low-dose rituximab and concurrent adjuvant therapy for pemphigus: Protocol and single-centre long-term review of nine patients.Efficacy and safety of rituximab therapy in patients with pemphigus vulgaris: first report from Turkey.Adjuvant rituximab treatment for pemphigus: A retrospective study of 45 patients at a single center with long-term follow up.British Association of Dermatologists' guidelines for the management of pemphigus vulgaris 2017.
P2860
Q33741941-B1823FD1-3717-4702-AC45-395A532E4D9AQ38128304-962038E4-414B-4F9C-B89C-19B0C58BFCCFQ38245848-C0919D21-8AAF-4145-9BE6-D61395778750Q39140326-EFB7E2A0-CA99-44C9-A8A4-0E6A29B24D84Q39366479-04894945-557F-4984-971C-300A28A9516FQ47977153-35206227-DB42-4136-B669-DEC46F127E01Q49382688-C6AA2651-1439-41DD-8940-B3C01E3EF1B0
P2860
Clinical experiences of different dosing schedules of rituximab in pemphigus with various disease severities.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical experiences of differ ...... th various disease severities.
@en
type
label
Clinical experiences of differ ...... th various disease severities.
@en
prefLabel
Clinical experiences of differ ...... th various disease severities.
@en
P2093
P2860
P356
P1476
Clinical experiences of differ ...... th various disease severities.
@en
P2093
P2860
P304
P356
10.1111/JDV.12080
P577
2013-01-29T00:00:00Z